Global Human Coagulation Factor Ⅷ Market Growth 2020-2025
According to this study, over the next five years the Human Coagulation Factor Ⅷ market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Coagulation Factor Ⅷ business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Coagulation Factor Ⅷ market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Human Coagulation Factor Ⅷ, covering the supply chain analysis, impact assessment to the Human Coagulation Factor Ⅷ market size growth rate in several scenarios, and the measures to be undertaken by Human Coagulation Factor Ⅷ companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Recombinant Factor VIII
Human Factor VIII
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hemophilia A
Relvent Bleeding Diseases
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Guangdong Shuanglin
CSL Behring
Grifols
Octapharma
Baxter
Shanghai Laishi
Pfizer
Hualan Bio
Taibang Bio
GreenCross
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Human Coagulation Factor Ⅷ consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Human Coagulation Factor Ⅷ market by identifying its various subsegments.
Focuses on the key global Human Coagulation Factor Ⅷ manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Coagulation Factor Ⅷ with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Coagulation Factor Ⅷ submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Coagulation Factor Ⅷ Consumption 2015-2025
2.1.2 Human Coagulation Factor Ⅷ Consumption CAGR by Region
2.2 Human Coagulation Factor Ⅷ Segment by Type
2.2.1 Recombinant Factor VIII
2.2.2 Human Factor VIII
2.3 Human Coagulation Factor Ⅷ Consumption by Type
2.3.1 Global Human Coagulation Factor Ⅷ Consumption Market Share by Type (2015-2020)
2.3.2 Global Human Coagulation Factor Ⅷ Revenue and Market Share by Type (2015-2020)
2.3.3 Global Human Coagulation Factor Ⅷ Sale Price by Type (2015-2020)
2.4 Human Coagulation Factor Ⅷ Segment by Application
2.4.1 Hemophilia A
2.4.2 Relvent Bleeding Diseases
2.5 Human Coagulation Factor Ⅷ Consumption by Application
2.5.1 Global Human Coagulation Factor Ⅷ Consumption Market Share by Type (2015-2020)
2.5.2 Global Human Coagulation Factor Ⅷ Value and Market Share by Type (2015-2020)
2.5.3 Global Human Coagulation Factor Ⅷ Sale Price by Type (2015-2020)
3 Global Human Coagulation Factor Ⅷ by Company
3.1 Global Human Coagulation Factor Ⅷ Sales Market Share by Company
3.1.1 Global Human Coagulation Factor Ⅷ Sales by Company (2018-2020)
3.1.2 Global Human Coagulation Factor Ⅷ Sales Market Share by Company (2018-2020)
3.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Company
3.2.1 Global Human Coagulation Factor Ⅷ Revenue by Company (2018-2020)
3.2.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Company (2018-2020)
3.3 Global Human Coagulation Factor Ⅷ Sale Price by Company
3.4 Global Human Coagulation Factor Ⅷ Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Human Coagulation Factor Ⅷ Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human Coagulation Factor Ⅷ Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Human Coagulation Factor Ⅷ by Regions
4.1 Human Coagulation Factor Ⅷ by Regions
4.2 Americas Human Coagulation Factor Ⅷ Consumption Growth
4.3 APAC Human Coagulation Factor Ⅷ Consumption Growth
4.4 Europe Human Coagulation Factor Ⅷ Consumption Growth
4.5 Middle East & Africa Human Coagulation Factor Ⅷ Consumption Growth
5 Americas
5.1 Americas Human Coagulation Factor Ⅷ Consumption by Countries
5.1.1 Americas Human Coagulation Factor Ⅷ Consumption by Countries (2015-2020)
5.1.2 Americas Human Coagulation Factor Ⅷ Value by Countries (2015-2020)
5.2 Americas Human Coagulation Factor Ⅷ Consumption by Type
5.3 Americas Human Coagulation Factor Ⅷ Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Human Coagulation Factor Ⅷ Consumption by Regions
6.1.1 APAC Human Coagulation Factor Ⅷ Consumption by Regions (2015-2020)
6.1.2 APAC Human Coagulation Factor Ⅷ Value by Regions (2015-2020)
6.2 APAC Human Coagulation Factor Ⅷ Consumption by Type
6.3 APAC Human Coagulation Factor Ⅷ Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Human Coagulation Factor Ⅷ by Countries
7.1.1 Europe Human Coagulation Factor Ⅷ Consumption by Countries (2015-2020)
7.1.2 Europe Human Coagulation Factor Ⅷ Value by Countries (2015-2020)
7.2 Europe Human Coagulation Factor Ⅷ Consumption by Type
7.3 Europe Human Coagulation Factor Ⅷ Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Human Coagulation Factor Ⅷ by Countries
8.1.1 Middle East & Africa Human Coagulation Factor Ⅷ Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human Coagulation Factor Ⅷ Value by Countries (2015-2020)
8.2 Middle East & Africa Human Coagulation Factor Ⅷ Consumption by Type
8.3 Middle East & Africa Human Coagulation Factor Ⅷ Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Coagulation Factor Ⅷ Distributors
10.3 Human Coagulation Factor Ⅷ Customer
11 Global Human Coagulation Factor Ⅷ Market Forecast
11.1 Global Human Coagulation Factor Ⅷ Consumption Forecast (2021-2025)
11.2 Global Human Coagulation Factor Ⅷ Forecast by Regions
11.2.1 Global Human Coagulation Factor Ⅷ Forecast by Regions (2021-2025)
11.2.2 Global Human Coagulation Factor Ⅷ Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Coagulation Factor Ⅷ Forecast by Type
11.8 Global Human Coagulation Factor Ⅷ Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Information
12.1.2 Human Coagulation Factor Ⅷ Product Offered
12.1.3 Bayer Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bayer Latest Developments
12.2 Guangdong Shuanglin
12.2.1 Company Information
12.2.2 Human Coagulation Factor Ⅷ Product Offered
12.2.3 Guangdong Shuanglin Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Guangdong Shuanglin Latest Developments
12.3 CSL Behring
12.3.1 Company Information
12.3.2 Human Coagulation Factor Ⅷ Product Offered
12.3.3 CSL Behring Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 CSL Behring Latest Developments
12.4 Grifols
12.4.1 Company Information
12.4.2 Human Coagulation Factor Ⅷ Product Offered
12.4.3 Grifols Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Grifols Latest Developments
12.5 Octapharma
12.5.1 Company Information
12.5.2 Human Coagulation Factor Ⅷ Product Offered
12.5.3 Octapharma Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Octapharma Latest Developments
12.6 Baxter
12.6.1 Company Information
12.6.2 Human Coagulation Factor Ⅷ Product Offered
12.6.3 Baxter Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Baxter Latest Developments
12.7 Shanghai Laishi
12.7.1 Company Information
12.7.2 Human Coagulation Factor Ⅷ Product Offered
12.7.3 Shanghai Laishi Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Shanghai Laishi Latest Developments
12.8 Pfizer
12.8.1 Company Information
12.8.2 Human Coagulation Factor Ⅷ Product Offered
12.8.3 Pfizer Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Pfizer Latest Developments
12.9 Hualan Bio
12.9.1 Company Information
12.9.2 Human Coagulation Factor Ⅷ Product Offered
12.9.3 Hualan Bio Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Hualan Bio Latest Developments
12.10 Taibang Bio
12.10.1 Company Information
12.10.2 Human Coagulation Factor Ⅷ Product Offered
12.10.3 Taibang Bio Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Taibang Bio Latest Developments
12.11 GreenCross
12.11.1 Company Information
12.11.2 Human Coagulation Factor Ⅷ Product Offered
12.11.3 GreenCross Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 GreenCross Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Human Coagulation Factor Ⅷ Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Recombinant Factor VIII
Table 5. Major Players of Human Factor VIII
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Human Coagulation Factor Ⅷ Consumption Market Share by Type (2015-2020)
Table 8. Global Human Coagulation Factor Ⅷ Revenue by Type (2015-2020) ($ million)
Table 9. Global Human Coagulation Factor Ⅷ Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Human Coagulation Factor Ⅷ Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Human Coagulation Factor Ⅷ Consumption Market Share by Application (2015-2020)
Table 13. Global Human Coagulation Factor Ⅷ Value by Application (2015-2020)
Table 14. Global Human Coagulation Factor Ⅷ Value Market Share by Application (2015-2020)
Table 15. Global Human Coagulation Factor Ⅷ Sale Price by Application (2015-2020)
Table 16. Global Human Coagulation Factor Ⅷ Sales by Company (2017-2019) (K Units)
Table 17. Global Human Coagulation Factor Ⅷ Sales Market Share by Company (2017-2019)
Table 18. Global Human Coagulation Factor Ⅷ Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Human Coagulation Factor Ⅷ Revenue Market Share by Company (2017-2019)
Table 20. Global Human Coagulation Factor Ⅷ Sale Price by Company (2017-2019)
Table 21. Global Human Coagulation Factor Ⅷ Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Human Coagulation Factor Ⅷ Products Offered
Table 23. Human Coagulation Factor Ⅷ Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Human Coagulation Factor Ⅷ Consumption by Regions 2015-2020 (K Units)
Table 25. Global Human Coagulation Factor Ⅷ Consumption Market Share by Regions 2015-2020
Table 26. Global Human Coagulation Factor Ⅷ Value by Regions 2015-2020 ($ Millions)
Table 27. Global Human Coagulation Factor Ⅷ Value Market Share by Regions 2015-2020
Table 28. Americas Human Coagulation Factor Ⅷ Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Human Coagulation Factor Ⅷ Consumption Market Share by Countries (2015-2020)
Table 30. Americas Human Coagulation Factor Ⅷ Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Human Coagulation Factor Ⅷ Value Market Share by Countries (2015-2020)
Table 32. Americas Human Coagulation Factor Ⅷ Consumption by Type (2015-2020) (K Units)
Table 33. Americas Human Coagulation Factor Ⅷ Consumption Market Share by Type (2015-2020)
Table 34. Americas Human Coagulation Factor Ⅷ Consumption by Application (2015-2020) (K Units)
Table 35. Americas Human Coagulation Factor Ⅷ Consumption Market Share by Application (2015-2020)
Table 36. APAC Human Coagulation Factor Ⅷ Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Human Coagulation Factor Ⅷ Consumption Market Share by Regions (2015-2020)
Table 38. APAC Human Coagulation Factor Ⅷ Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Human Coagulation Factor Ⅷ Value Market Share by Regions (2015-2020)
Table 40. APAC Human Coagulation Factor Ⅷ Consumption by Type (2015-2020) (K Units)
Table 41. APAC Human Coagulation Factor Ⅷ Consumption Market Share by Type (2015-2020)
Table 42. APAC Human Coagulation Factor Ⅷ Consumption by Application (2015-2020) (K Units)
Table 43. APAC Human Coagulation Factor Ⅷ Consumption Market Share by Application (2015-2020)
Table 44. Europe Human Coagulation Factor Ⅷ Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Human Coagulation Factor Ⅷ Consumption Market Share by Countries (2015-2020)
Table 46. Europe Human Coagulation Factor Ⅷ Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Human Coagulation Factor Ⅷ Value Market Share by Countries (2015-2020)
Table 48. Europe Human Coagulation Factor Ⅷ Consumption by Type (2015-2020) (K Units)
Table 49. Europe Human Coagulation Factor Ⅷ Consumption Market Share by Type (2015-2020)
Table 50. Europe Human Coagulation Factor Ⅷ Consumption by Application (2015-2020) (K Units)
Table 51. Europe Human Coagulation Factor Ⅷ Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Human Coagulation Factor Ⅷ Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Human Coagulation Factor Ⅷ Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Human Coagulation Factor Ⅷ Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Human Coagulation Factor Ⅷ Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Human Coagulation Factor Ⅷ Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Human Coagulation Factor Ⅷ Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Human Coagulation Factor Ⅷ Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Human Coagulation Factor Ⅷ Consumption Market Share by Application (2015-2020)
Table 60. Human Coagulation Factor Ⅷ Distributors List
Table 61. Human Coagulation Factor Ⅷ Customer List
Table 62. Global Human Coagulation Factor Ⅷ Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Human Coagulation Factor Ⅷ Consumption Market Forecast by Regions
Table 64. Global Human Coagulation Factor Ⅷ Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Human Coagulation Factor Ⅷ Value Market Share Forecast by Regions
Table 66. Global Human Coagulation Factor Ⅷ Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Human Coagulation Factor Ⅷ Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Human Coagulation Factor Ⅷ Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Human Coagulation Factor Ⅷ Value Market Share Forecast by Type (2021-2025)
Table 70. Global Human Coagulation Factor Ⅷ Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Human Coagulation Factor Ⅷ Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Human Coagulation Factor Ⅷ Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Human Coagulation Factor Ⅷ Value Market Share Forecast by Application (2021-2025)
Table 74. Bayer Product Offered
Table 75. Bayer Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. Bayer Main Business
Table 77. Bayer Latest Developments
Table 78. Bayer Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 79. Guangdong Shuanglin Product Offered
Table 80. Guangdong Shuanglin Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. Guangdong Shuanglin Main Business
Table 82. Guangdong Shuanglin Latest Developments
Table 83. Guangdong Shuanglin Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Behring Product Offered
Table 85. CSL Behring Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. CSL Behring Main Business
Table 87. CSL Behring Latest Developments
Table 88. CSL Behring Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 89. Grifols Product Offered
Table 90. Grifols Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Grifols Main Business
Table 92. Grifols Latest Developments
Table 93. Grifols Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 94. Octapharma Product Offered
Table 95. Octapharma Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Octapharma Main Business
Table 97. Octapharma Latest Developments
Table 98. Octapharma Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 99. Baxter Product Offered
Table 100. Baxter Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. Baxter Main Business
Table 102. Baxter Latest Developments
Table 103. Baxter Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai Laishi Product Offered
Table 105. Shanghai Laishi Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 106. Shanghai Laishi Main Business
Table 107. Shanghai Laishi Latest Developments
Table 108. Shanghai Laishi Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 109. Pfizer Product Offered
Table 110. Pfizer Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Pfizer Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 114. Hualan Bio Product Offered
Table 115. Hualan Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 116. Hualan Bio Main Business
Table 117. Hualan Bio Latest Developments
Table 118. Hualan Bio Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 119. Taibang Bio Product Offered
Table 120. Taibang Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 121. Taibang Bio Main Business
Table 122. Taibang Bio Latest Developments
Table 123. Taibang Bio Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor Ⅷ Manufacturing Base, Sales Area and Its Competitors
Table 124. GreenCross Product Offered
Table 125. GreenCross Human Coagulation Factor Ⅷ Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 126. GreenCross Main Business
Table 127. GreenCross Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. GreenCross Latest Developments
List of Figures
Figure 1. Picture of Human Coagulation Factor Ⅷ
Figure 2. Human Coagulation Factor Ⅷ Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Human Coagulation Factor Ⅷ Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Human Coagulation Factor Ⅷ Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Recombinant Factor VIII
Figure 7. Product Picture of Human Factor VIII
Figure 8. Global Human Coagulation Factor Ⅷ Consumption Market Share by Type (2015-2020)
Figure 9. Global Human Coagulation Factor Ⅷ Value Market Share by Type (2015-2020)
Figure 10. Human Coagulation Factor Ⅷ Consumed in Hemophilia A
Figure 11. Global Human Coagulation Factor Ⅷ Market: Hemophilia A (2015-2020) (K Units)
Figure 12. Global Human Coagulation Factor Ⅷ Market: Hemophilia A (2015-2020) ($ Millions)
Figure 13. Human Coagulation Factor Ⅷ Consumed in Relvent Bleeding Diseases
Figure 14. Global Human Coagulation Factor Ⅷ Market: Relvent Bleeding Diseases (2015-2020) (K Units)
Figure 15. Global Human Coagulation Factor Ⅷ Market: Relvent Bleeding Diseases (2015-2020) ($ Millions)
Figure 16. Global Human Coagulation Factor Ⅷ Consumption Market Share by Application (2015-2020)
Figure 17. Global Human Coagulation Factor Ⅷ Value Market Share by Application (2015-2020)
Figure 18. Global Human Coagulation Factor Ⅷ Sales Market Share by Company in 2017
Figure 19. Global Human Coagulation Factor Ⅷ Sales Market Share by Company in 2019
Figure 20. Global Human Coagulation Factor Ⅷ Revenue Market Share by Company in 2017
Figure 21. Global Human Coagulation Factor Ⅷ Revenue Market Share by Company in 2019
Figure 22. Global Human Coagulation Factor Ⅷ Sale Price by Company in 2019
Figure 23. Global Human Coagulation Factor Ⅷ Consumption Market Share by Regions 2015-2020
Figure 24. Global Human Coagulation Factor Ⅷ Value Market Share by Regions 2015-2020
Figure 25. Americas Human Coagulation Factor Ⅷ Consumption 2015-2020 (K Units)
Figure 26. Americas Human Coagulation Factor Ⅷ Value 2015-2020 ($ Millions)
Figure 27. APAC Human Coagulation Factor Ⅷ Consumption 2015-2020 (K Units)
Figure 28. APAC Human Coagulation Factor Ⅷ Value 2015-2020 ($ Millions)
Figure 29. Europe Human Coagulation Factor Ⅷ Consumption 2015-2020 (K Units)
Figure 30. Europe Human Coagulation Factor Ⅷ Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Human Coagulation Factor Ⅷ Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Human Coagulation Factor Ⅷ Value 2015-2020 ($ Millions)
Figure 33. Americas Human Coagulation Factor Ⅷ Consumption Market Share by Countries in 2019
Figure 34. Americas Human Coagulation Factor Ⅷ Value Market Share by Countries in 2019
Figure 35. Americas Human Coagulation Factor Ⅷ Consumption Market Share by Type in 2019
Figure 36. Americas Human Coagulation Factor Ⅷ Consumption Market Share by Application in 2019
Figure 37. United States Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 38. United States Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Human Coagulation Factor Ⅷ Consumption Market Share by Countries in 2019
Figure 44. APAC Human Coagulation Factor Ⅷ Value Market Share by Regions in 2019
Figure 45. APAC Human Coagulation Factor Ⅷ Consumption Market Share by Type in 2019
Figure 46. APAC Human Coagulation Factor Ⅷ Consumption Market Share by Application in 2019
Figure 47. China Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 48. China Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 55. India Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 56. India Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Human Coagulation Factor Ⅷ Consumption Market Share by Countries in 2019
Figure 60. Europe Human Coagulation Factor Ⅷ Value Market Share by Countries in 2019
Figure 61. Europe Human Coagulation Factor Ⅷ Consumption Market Share by Type in 2019
Figure 62. Europe Human Coagulation Factor Ⅷ Consumption Market Share by Application in 2019
Figure 63. Germany Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 65. France Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 66. France Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 67. UK Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 68. UK Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Human Coagulation Factor Ⅷ Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Human Coagulation Factor Ⅷ Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Human Coagulation Factor Ⅷ Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Human Coagulation Factor Ⅷ Consumption Market Share by Application in 2019
Figure 77. Egypt Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Human Coagulation Factor Ⅷ Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Human Coagulation Factor Ⅷ Value Growth 2015-2020 ($ Millions)
Figure 87. Global Human Coagulation Factor Ⅷ Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Human Coagulation Factor Ⅷ Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 90. Americas Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 91. APAC Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 92. APAC Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 93. Europe Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 94. Europe Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 97. United States Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 98. United States Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 99. Canada Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 100. Canada Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 101. Mexico Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 102. Mexico Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 103. Brazil Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 104. Brazil Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 105. China Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 106. China Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 107. Japan Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 108. Japan Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 109. Korea Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 110. Korea Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 113. India Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 114. India Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 115. Australia Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 116. Australia Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 117. Germany Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 118. Germany Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 119. France Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 120. France Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 121. UK Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 122. UK Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 123. Italy Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 124. Italy Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 125. Russia Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 126. Russia Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 127. Spain Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 128. Spain Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 129. Egypt Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 130. Egypt Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 131. South Africa Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 132. South Africa Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 133. Israel Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 134. Israel Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 135. Turkey Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 136. Turkey Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Human Coagulation Factor Ⅷ Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Human Coagulation Factor Ⅷ Value 2021-2025 ($ Millions)
Figure 139. Bayer Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 140. Guangdong Shuanglin Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 141. CSL Behring Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 142. Grifols Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 143. Octapharma Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 144. Baxter Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 145. Shanghai Laishi Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 146. Pfizer Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 147. Hualan Bio Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 148. Taibang Bio Human Coagulation Factor Ⅷ Market Share (2018-2020)
Figure 149. GreenCross Human Coagulation Factor Ⅷ Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets